Bethesda, Md. – AABB (formerly known as the American Association of Blood Banks) has installed Michael Murphy, MD, FRCP, FRCPath, FFPath, as its president for the 2018-2019 term. Murphy was inaugurated during the 2018 AABB Annual Meeting, which ends today in Boston, Mass. He succeeds Mary Beth Bassett, BS, MT(ASCP).
“It is a great honor for me to become the next president of AABB. I consider this role to be an important and challenging responsibility, but one that I undertake very willingly and respectfully,” said AABB’s new President Michael Murphy. “I will work with my colleagues on the Board of Directors and AABB’s CEO to continue to work to advance transfusion medicine, cellular therapies and patient blood management. Together, we will continue to adhere to AABB’s vision of making transfusion medicine and cellular therapies safe, available and effective worldwide.”
Murphy is a Professor of Transfusion Medicine at the University of Oxford and a Consultant Haematologist for NHS Blood & Transplant and the Oxford University Hospitals NHS Foundation Trust in England. His research focuses on the use of new technologies for the transfusion process, the transfusion supportive care of hematology patients and the management of neonatal alloimmune thrombocytopenia.
In addition to his service on the AABB Board of Directors, Murphy was an adviser on the AABB Interorganizational Task Force on Biovigilance and served on AABB's Clinical Transfusion Medicine and Annual Meeting Program Committees. He was also involved in developing transfusion guidelines for the British Committee for Standards in Haematology. Murphy is the current chair of the BEST Collaborative, an international research group exploring ways to improve transfusion-related services. Throughout his career, Murphy has authored more than 250 scientific articles.
Murphy received his medical degree and trained in hematology at St. Bartholomew's Hospital Medical College in London.
AABB members also elected Beth Shaz, MD, as the 2019-2020 Association president; Richard Schäfer, MD, as at-large director; Tony Casina, MT(ASCP)SBB, as at-large director; Celina Montemayor, MD, PhD, as appointed director; and Deborah Sesok-Pizzini, MD, MBA, as CT Section Representative Director.
AABB is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and cellular therapies. The association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries.